Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by francois21on Sep 21, 2016 10:36am

232 Views

Post# 25260397

RE:RE:RE:Short position PLI septembre 15th

The short positionnot reported on TSX, as the american funds will declare their short position on the OTC, even if they short on the TSX is much higher:

Date	Short Interest	% Change	Avg. Daily Share Volume	Days to Cover	Split	New Issue
Aug 31, 2016	21,034,200	20.91	51,108	411.56	No	No
Aug 15, 2016	17,395,964	16.13	81,613	213.15	No	No
Jul 29, 2016	14,980,212	0.83	81,792	183.15	No	No
Jul 15, 2016	14,857,307	2.80	29,367	505.92	No	No
Jun 30, 2016	14,451,963	7.18	12,419	999.99	No	No
Jun 15, 2016	13,483,912	4.97	24,762	544.54	No	No
May 31, 2016	12,464,727	-8.69	64,832	192.26	No	No